Please use this identifier to cite or link to this item:
https://doi.org/10.3402/pba.v2i0.17391
Title: | Breast tumors in PyMT transgenic mice expressing mitochondrial catalase have decreased labeling for macrophages and endothelial cells. | Authors: | Fatemie, Sy Goh, Jorming Pettan-Brewer, Christina Ladiges, Warren |
Keywords: | endothelial cells immunohistochemistry of mouse breast cancer mitochondrial catalase reactive oxygen species tumor associated macrophages |
Issue Date: | 2012 | Publisher: | Informa UK Limited | Citation: | Fatemie, Sy, Goh, Jorming, Pettan-Brewer, Christina, Ladiges, Warren (2012). Breast tumors in PyMT transgenic mice expressing mitochondrial catalase have decreased labeling for macrophages and endothelial cells.. Pathobiol Aging Age Relat Dis 2 (1) : 17391-17391. ScholarBank@NUS Repository. https://doi.org/10.3402/pba.v2i0.17391 | Abstract: | We show by immunohistochemical labeling that prominent cell types in the tumor microenvironment of PyMT transgenic mice are tumor-associated macrophages (TAMs) and endothelial cells, and that both populations are decreased in the presence of mitochondrial targeted catalase (mCAT). This observation suggests that mitochondrial ROS can drive tumor invasiveness in conjunction with the presence of TAMs and increased angiogenesis. Since primary PyMT tumor cells expressing mCAT undergo increased apoptosis, mitochondrial antioxidants might be attractive anti-tumor agents. | Source Title: | Pathobiol Aging Age Relat Dis | URI: | https://scholarbank.nus.edu.sg/handle/10635/219462 | ISSN: | 2001-0001 | DOI: | 10.3402/pba.v2i0.17391 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Breast tumors in PyMT transgenic mice expressing mitochondrial catalase have decreased labeling for macrophages and endothel.pdf | 2.26 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.